Press release
Molecular Infectious Disease Testing Market Anticipated To Reach USD 34.73 Billion By 2034 | CAGR: 13.5%
Molecular Infectious Disease Testing Market
Market Overview
The superior susceptibility and accuracy linked with the usage of molecular assays have profoundly enhanced the field of infectious disease diagnosis by offering clinicians outcomes that are both precise and rapidly obtained. Molecular infectious disease testing provides many benefits involving rapid test outcomes, easing judgement of epidemics and, in some cases, fresh strains and susceptibility, accuracy, recognition of impenetrable organisms, and measurable association to disease gravity, all of which cause timely therapeutic clinical decisions and premature infection regulation mediations. These procedures are capable of recognizing organisms that might be complex to detach and have not been cultured by conventional methods.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/molecular-infectious-disease-testing-market/request-for-sample
Market Key Players
The top market players use strategic developments such as product advancements, research and development funding, and mergers and acquisitions to fortify their market position. Key companies are mentioned below:
• Abbott
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Grifols S.A.
• Hologic, Inc. (Gen-Probe)
Key Market Highlights
Growing Prevalence of Sexually Transferred Infections: The growing prevalence of illnesses such as sexually transferred infections, respiratory infections, and surfacing pathogens has pushed the requirement for precise and speedy detection procedures. As per a 2021 analysis by Our World in Data, there were roughly 560,843 infectious disease-connected terminations in the US in 2021. This rising prevalence is driving the molecular infectious disease testing market demand.
Technological Innovations: Innovations such as real-time PCR, digital PCR, and next-generation sequencing have exceptionally enhanced the capacity to inspect pathogens with higher accuracy and decreased turnaround time. In June 2024, QIAGEN instigated 35 advanced digital PCR Microbial DNA Detection Assays for its QIAcuity platform, aiming at pathogens giving rise to tropical illnesses, STIs, and UTIs.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/molecular-infectious-disease-testing-market/request-for-discount-pricing
Segmental Outlook
By Product & Service Outlook (Revenue, USD Billion, 2020-2034)
• Reagents & Kits
• Instruments
• Services & Software
By Type Outlook (Revenue, USD Billion, 2020-2034)
• Multiplex Testing
• Singleplex Testing
By Test Type Outlook (Revenue, USD Billion, 2020-2034)
• Laboratory Tests
• Point-of-Care Tests
By Disease Outlook (Revenue, USD Billion, 2020-2034)
• Respiratory Infectious Diseases
• Gastrointestinal Infectious Diseases
• Sexually Transmitted Diseases
• Hospital-Acquired Infections
• Vaginitis
• Meningitis
• Vector-Borne Diseases
• Other Infectious Diseases
By Technology Outlook (Revenue, USD Billion, 2020-2034)
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA-Sequencing & Next-Generation Sequencing
• In-Situ Hybridization
• DNA Microarrays
• Others
By End User Outlook (Revenue, USD Billion, 2020-2034)
• Diagnostic Laboratories
• Hospitals & Clinics
• Others
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/molecular-infectious-disease-testing-market
Country-wise Insights
By region, the market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America held the largest molecular infectious disease testing market share in 2024 owing to enhanced healthcare infrastructure, high acquisition rate of progressive diagnostic technologies, and robust regulatory structure reinforcing molecular testing.
Asia Pacific is the fastest-growing market in the region due to growing healthcare funding, growing consciousness of early disease detection, and the rising burden of infectious illnesses.
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports By Polaris Market Research:
Home Healthcare Market:
Cultured Meat Market
Rainwear Market https://www.polarismarketresearch.com/industry-analysis/rainwear-market
X-Ray Security Screening Market https://www.polarismarketresearch.com/industry-analysis/x-ray-security-screening-market
Interior Design Services Market https://www.polarismarketresearch.com/industry-analysis/interior-design-services-market
Mental Health Teletherapy Platform Solutions Market https://www.polarismarketresearch.com/industry-analysis/mental-health-teletherapy-platform-solutions-market
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Molecular Infectious Disease Testing Market Anticipated To Reach USD 34.73 Billion By 2034 | CAGR: 13.5% here
News-ID: 3961441 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
